The case involved a clinical trial of Akero's only product, a drug candidate aimed at treating a liver disease. It's the ...

Individual brings two decades of industry experience to his new role, and has also previously worked at Refinitiv, Bloomberg ...

Manitoba’s near-top position likely results from its relatively low numbers, noted Rebecca Oakes, Equifax Canada vice-president of advanced analytics. The credit reporting agency tracked an average ...

A new Equifax® (NYSE:EFX) survey shows that human resources (HR) leaders are facing challenges using technology innovation to ...

Regional dynamics also show widening stress with Ontario’s non-mortgage delinquency rate rising to 1.75% led by Toronto, the ...

In Q2 2025, close to 1.4 million Canadians missed a credit payment — 7,000 fewer than last quarter – but still 118,000 more ...

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of ...

Rebecca Oakes, vice-president of advanced analytics at Equifax Canada, said it's "a bit of good news" to see the delinquency ...

In early 2025, AMC announced a new competition series, Guts & Glory, from award-winning SFX master and Walking Dead executive ...

Quality boots, weather systems, and field accessories were among the highlights of this year's product launches. Here’s what ...

Akero Therapeutics (AKRO) announced publication of 96-week final results from the Phase 2b HARMONY trial in The Lancet in adults with ...

Results support potential of efruxifermin (EFX) to reduce risk of fibrosis progression in patients with pre-cirrhotic (F2-F3) MASH ...